Clinical trial
Cyclophosphamide in Lupus Nephritis
NCT00441220 · University of Auckland, New Zealand, Other · Unknown status
Key facts
| NCT number | NCT00441220 |
|---|---|
| Title | Cyclophosphamide in Lupus Nephritis |
| Official title | Failure of Cyclophosphamide Therapy in Lupus Nephritis Patients: the Role of Bioactivation Phenotype and Genotype |
| Lead sponsor | University of Auckland, New Zealand, Other |
| Collaborators | Auckland District Health Board Counties Manukau Health Auckland Medical Research Foundation Arthritis New Zealand |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Systemic Lupus Erythematosus |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| Completion | Oct 1, 2010 |
| First posted | Feb 28, 2007 |
| Last update posted | Mar 5, 2009 |
| Countries | New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: